Phase 4 Alzheimer's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged 20 years or older.
- People with a Clinical Dementia Rating (CDR) score of 0.5 — this is a scale used to measure mild memory and thinking changes, and a score of 0.5 indicates very mild impairment (confirm with trial site).
- People for whom a doctor has determined that treatment with Ginkgo biloba extract is clinically appropriate.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People currently taking medications known as cholinesterase inhibitors, such as donepezil, rivastigmine, or galantamine.
- People who decline to give their formal agreement to take part in the trial.
- People who have a neurological or psychiatric condition other than Alzheimer's disease that could affect memory or thinking.
- People with a known allergy or sensitivity to Ginkgo biloba extract or any of its ingredients.
- People who are pregnant.
- People with certain genetic conditions related to difficulty processing lactose or related sugars, including galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption.
- People who have a bleeding disorder, or who need to take certain ongoing medications that may interfere with the study drug — such as blood thinners, anticlotting medications, clot-dissolving medications, or certain blood flow medications.
- People whom the trial investigators or staff consider unsuitable for the study for any other reason, or who may not be able to follow the study procedures.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +82-31-560-2264
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Change from Baseline in Plasma p-tau217 at 6 Months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.